↓ Skip to main content

Dove Medical Press

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
patent
23 patents
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
146 Mendeley
Title
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Published in
Therapeutics and Clinical Risk Management, August 2008
DOI 10.2147/tcrm.s3470
Pubmed ID
Authors

Stephanie Hennigan, Arthur Kavanaugh

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
United States 1 <1%
Czechia 1 <1%
Singapore 1 <1%
Unknown 142 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 16%
Student > Bachelor 23 16%
Student > Master 19 13%
Student > Doctoral Student 14 10%
Researcher 14 10%
Other 22 15%
Unknown 30 21%
Readers by discipline Count As %
Medicine and Dentistry 41 28%
Biochemistry, Genetics and Molecular Biology 16 11%
Agricultural and Biological Sciences 16 11%
Pharmacology, Toxicology and Pharmaceutical Science 13 9%
Immunology and Microbiology 8 5%
Other 18 12%
Unknown 34 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#2,242,566
of 25,377,790 outputs
Outputs from Therapeutics and Clinical Risk Management
#99
of 1,323 outputs
Outputs of similar age
#6,235
of 97,953 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 7 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,953 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.